Form 8-K - Current report:
SEC Accession No. 0000950170-23-000127
Filing Date
2023-01-04
Accepted
2023-01-04 16:22:55
Documents
18
Period of Report
2023-01-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gern-20230104.htm   iXBRL 8-K 62387
2 UPDATED COMPANY DISCLOSURE gern-ex99_1.htm EX-99.1 1128220
3 GRAPHIC img50521483_0.jpg GRAPHIC 571926
4 GRAPHIC img50521483_1.jpg GRAPHIC 381560
5 GRAPHIC img50521483_2.jpg GRAPHIC 536768
6 GRAPHIC img50521483_3.jpg GRAPHIC 425397
7 GRAPHIC img50521483_4.jpg GRAPHIC 532036
  Complete submission text file 0000950170-23-000127.txt   4838320

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gern-20230104_pre.xml EX-101.PRE 10833
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gern-20230104_lab.xml EX-101.LAB 13352
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gern-20230104.xsd EX-101.SCH 2367
12 EXTRACTED XBRL INSTANCE DOCUMENT gern-20230104_htm.xml XML 4702
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20859 | Film No.: 23506779
SIC: 2834 Pharmaceutical Preparations